Name AMBIKA HANDIQUI UHID no.

376634
Referred By G_CHIRAG J DESAI Sample Rec. Date 27/12/16 06:28 PM

XRAY CHEST PA VIEW

FINDINGS: : Lung fields are clear.

Mild cardiomegaly noted.

Both costophrenic angles are clear.

Domes of diaphragm are well delineated.

Sternal sutures seen.

Note: This is a representative electronic report of the lab results. Kindly contact the hospital for the final lab test report.

Page 1 www.apolloprism.com
 Name AMBIKA HANDIQUI UHID no. 376634
Referred By G_CHIRAG J DESAI Sample Rec. Date 27/12/16 06:48 PM

COMPLETE BLOOD COUNT (CBC)

Total WBC Count 12340 /cumm

P.C.V 35.6 %

MCV 75.2 fL

MCH 24.3 pg

MCHC 32.4 %

Haemoglobin 11.5 gms%

RBC Count 4.74 million/cumm

Platelet Count 177500 /cumm

Neutrophils 76 %

Lymphocytes 19 %

Monocytes 04 %

Eosinophils 01 %

Basophils 00 %

Method : : BECKMAN COULTER LH780

XRAY CHEST PA VIEW

Note: This is a representative electronic report of the lab results. Kindly contact the hospital for the final lab test report.

Page 2 www.apolloprism.com
FINDINGS: : Lung fields are clear.

Mild cardiomegaly noted.

Both costophrenic angles are clear.

Domes of diaphragm are well delineated.

Sternal sutures seen.

POTASSIUM - SERUM

Serum Potassium 4.2 mmol/l

CREATININE - SERUM

Serum Creatinine 1.4 mg/dl

Collected at: 12:30 PM

BLOOD GLUCOSE(RANDOM)

Investigation Result Unit Range

Blood Glucose Random 115 mg/dl 70-140

TSH-THYROID STIMULATING HORMONE

Serum-TSH 3.57 µIU/mL

URINE FOR ROUTINE EXAMINATION

Volume 20 ml

Note: This is a representative electronic report of the lab results. Kindly contact the hospital for the final lab test report.

Page 3 www.apolloprism.com
Specific Gravity 1.030

Colour Pale
Yellow

Appearance: Slightly
Hazy

Reaction Acidic

Albumin ++

Urine Sugar Nil

Ketone Bodies Absent

Bile Pigments Absent

Urobilinogen Normal

Nitrite Negative

Pus Cells 15-20/hpf

RBC 5-6/hpf

Epithelial Cells : 6-8/hpf

Casts Nil

Crystals. Nil

ECHO WITHOUT CASSETTE

Note: This is a representative electronic report of the lab results. Kindly contact the hospital for the final lab test report.

Page 4 www.apolloprism.com
FINDINGS: : Post MVR STATUS

Normally functioning prosthetic Mitral valve seen in situ.

Effective MVA: 2.7 Sq cm, Mild MR.

Mitral valve: Peak/Mean gradient:- 6 / 2.7 mm Hg.

Mildly dilated LA & LV cavity.

Mild LV systolic dysfunction, LVEF: 45-50%.

Mild Global LV Hypokinesia.

Rest cardiac valves are structurally normal.

IAS / IVS intact.

No AR, Trivial TR.

No PAH, RVSP: 30 mm Hg.

No clots / vegetation / effusion.

CONCLUSION : : Post MVR Status.

Normally functioning prosthetic Mitral valve in situ.
Effective MVA: 2.7 Sq cm, Mild MR.
Mild TR, Mild PAH, RVSP: 37 mm Hg.
Mild Global LV Hypokinesia.
Mild LV dysfunction, LVEF: 45-50%.

HBsAg

HBs Ag Negative

Note: This is a representative electronic report of the lab results. Kindly contact the hospital for the final lab test report.

Page 5 www.apolloprism.com
Interpretation : is the earliest marker of acute HBV infection which typically becomes detectable 2-
3 months (as early as 14 days) after infection. When symptoms of hepatitis are present, most patient
s have detectable HBsAg although few patients will have neither HBsAg nor anti-HBs and anti-
HBc IgM is the only marker of acute HBV infection (Core window). HBsAg typically persists for 12-
20 weeks after onset of symptoms in uncomplicated HBV infection and
disappears followed by a small but variable gap with onset of anti-HBs (Seroconversion).
of HBsAg beyond 06 months defines chronic HBV infection or a chronic carrier state. Chronic HBV i
nfection is seen in 1-2% of adults and adolescents following acute HBV infection, 5-
10% of immunocompromised individuals and upto 80% of neonates. The chronic carrier state of HB
V shows only persistent HBsAg in the serum without any other HBV marker or evidence of liver injur
y.
o f a n t i -
HBs without detectable HBsAg indicates recovery from acute HBV infection, absence of infectivity a
nd immunity against future HBV infection.
HBsAg assays are routinely used to aid in the diagnosis of suspected hepatitis B viral (HBV) infectio
n and to monitor the status of infected individuals.
CAUTION
initial reactive specimens are subjected to further testing by one or two additional methods and final
report is issued in accordance with the same.
Repeat reactive specimens MUST be confirmed by any combination of the confirmatory tests (e.g. H
BsAg neutralization test, Other HBV markers & LFT and HBV DNA by PCR method).
the HBsAg results are inconsistent with clinical evidence, additional testing is suggested to confirm t
he result.
diagnostic purposes, results should be used in conjunction with patient history and other hepatitis m
arkers for diagnosis of acute or chronic infection.

HEPATITIS C VIRUS ANTIBODIES

Hepatitis C virus antibodies Non-

Reactive

Note: This is a representative electronic report of the lab results. Kindly contact the hospital for the final lab test report.

Page 6 www.apolloprism.com
 Name AMBIKA HANDIQUI UHID no. 376634
Referred By G_CHIRAG J DESAI Sample Rec. Date 31/12/16 03:58 PM

PT - PROTHROMBIN TIME - PLASMA

Investigation Result Unit Range

Test 12.7 seconds 11-16

INR (International Normalised Ratio) 1.05 Normal: 0.8-1.2

Therapeutic Range:
2.0-3.5

Control 12.1 seconds

Note: This is a representative electronic report of the lab results. Kindly contact the hospital for the final lab test report.

Page 7 www.apolloprism.com
 Name AMBIKA HANDIQUI UHID no. 376634
Referred By JAY KOTHARI Sample Rec. Date 06/01/17 03:53 PM

PT - PROTHROMBIN TIME - PLASMA

Investigation Result Unit Range

Test 18.8 seconds 11-16

INR (International Normalised Ratio) 1.54 Normal: 0.8-1.2

Therapeutic Range:
2.0-3.5

Control 12.1 seconds

BLOOD GLUCOSE(FASTING)

Investigation Result Unit Range

Blood Glucose Fasting 142 mg/dl 70-100 : Normal

BLOOD GLUCOSE(P PRANDIAL/P GLUCOSE/RANDOM)

Investigation Result Unit Range

Blood Glucose Post Prandial 195 mg/dl 70-130

Note: This is a representative electronic report of the lab results. Kindly contact the hospital for the final lab test report.

Page 8 www.apolloprism.com
 Name AMBIKA HANDIQUI UHID no. 376634
Referred By SUBIR GHOSH Sample Rec. Date 15/11/17 12:49 PM

ECHO WITHOUT CASSETTE

FINDINGS: : Post MVR STATUS

Normally functioning prosthetic Mitral valve seen in situ.

Effective MVA: 2.5 Sq cm, No MR.

Mitral valve: Peak/Mean gradient:- 4 / 2 mm Hg.

Normal LA, LV & RA, RV size.

Normal LV systolic function, LVEF: 60%.

No Regional wall motion abnormalities.

Aortic valve: Mildly thickened, No AR.

Other cardiac valves are structurally normal.

IAS / IVS intact.

Mild PR, Mild TR.

No PAH, RVSP: 30 mm Hg.

No clots / vegetation / effusion.

CONCLUSION : : Post MVR Status.

Normally functioning prosthetic Mitral valve in situ.
Effective MVA: 2.5 Sq cm, Mild MR, Mild TR, No PAH.
Normal LV systolic function, LVEF: 60%.

Note: This is a representative electronic report of the lab results. Kindly contact the hospital for the final lab test report.

Page 9 www.apolloprism.com